The application of capsule endoscope system in the follow-up of patients with esophageal diseases

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100049559

Enrollment

Unknown

Registered

2021-08-02

Start date

2019-01-01

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal diseases

Interventions

1:NA

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1)Adults (ages 18–75 years) 2)Patients with history (by patient report) of esophageal organic diseases (esophageal varices, erosive esophagitis, postoperative esophageal ESD/EMR, Barrett's esophagus, esophageal polyps, esophageal achalasia, hiatal hernia) who planned to re-exam EGD after treatment; 3)Patients signed the informed consent

Exclusion criteria

Exclusion criteria: 1)no surgical conditions or refused any abdominal surgery (the capsule could not be removed by surgery once it was stuck) 2)implantation of cardiac pacemakers 3)other implanted electronic or magnetic instruments(electronic cochlea, magnetic metal drug infusion pump, nerve stimulator, et al) 4)pregnant women 5)dysphagia; known or suspected gastrointestinal tract obstruction, stenosis or fistula; history of abdominal surgery or abdominal radiation 6)contraindications of EGD 7)some inappropriate situation believed by researchers

Design outcomes

Primary

Measure	Time frame
gastroscope; capsule endoscope system;	—

Countries

P.R.China

Contacts

Public ContactZhujinshui

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

zhujs1803@163.com+86 18930177024

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026